Galapagos | Attività Correnti



Current Assets Cambiamento Data
AstraZeneca USD 26.14B 312M 2025-03
Biogen USD 7.46B 626.3M 2024-12
Genmab DKK 27.85B 4.16B 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
GRIFOLS EUR 5.73B 404.28M 2024-12
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Incyte USD 3.23B 7.24M 2025-03
Merck EUR 13.45B 479M 2024-12
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 44.02B 1.43B 2025-03
UCB EUR 4.79B 1.47B 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



Galapagos Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.